ZA839269B - Antibiotic a51568 factors a and b - Google Patents

Antibiotic a51568 factors a and b

Info

Publication number
ZA839269B
ZA839269B ZA839269A ZA839269A ZA839269B ZA 839269 B ZA839269 B ZA 839269B ZA 839269 A ZA839269 A ZA 839269A ZA 839269 A ZA839269 A ZA 839269A ZA 839269 B ZA839269 B ZA 839269B
Authority
ZA
South Africa
Prior art keywords
antibiotic
factors
formula
pharmaceutically acceptable
acceptable salt
Prior art date
Application number
ZA839269A
Other languages
English (en)
Inventor
Marvin Martin Hoehn
Gary G Marconi
G Marconi Gary
Original Assignee
Lilly Co Eli
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Lilly Co Eli filed Critical Lilly Co Eli
Publication of ZA839269B publication Critical patent/ZA839269B/xx

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K9/00—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof
    • C07K9/006—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure
    • C07K9/008—Peptides having up to 20 amino acids, containing saccharide radicals and having a fully defined sequence; Derivatives thereof the peptide sequence being part of a ring structure directly attached to a hetero atom of the saccharide radical, e.g. actaplanin, avoparcin, ristomycin, vancomycin
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12P—FERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P1/00—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes
    • C12P1/06—Preparation of compounds or compositions, not provided for in groups C12P3/00 - C12P39/00, by using microorganisms or enzymes by using actinomycetales
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
    • A61P31/04—Antibacterial agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • C12N1/205—Bacterial isolates
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12R—INDEXING SCHEME ASSOCIATED WITH SUBCLASSES C12C - C12Q, RELATING TO MICROORGANISMS
    • C12R2001/00—Microorganisms ; Processes using microorganisms
    • C12R2001/01—Bacteria or Actinomycetales ; using bacteria or Actinomycetales
    • C12R2001/365—Nocardia
    • Y—GENERAL TAGGING OF NEW TECHNOLOGICAL DEVELOPMENTS; GENERAL TAGGING OF CROSS-SECTIONAL TECHNOLOGIES SPANNING OVER SEVERAL SECTIONS OF THE IPC; TECHNICAL SUBJECTS COVERED BY FORMER USPC CROSS-REFERENCE ART COLLECTIONS [XRACs] AND DIGESTS
    • Y02—TECHNOLOGIES OR APPLICATIONS FOR MITIGATION OR ADAPTATION AGAINST CLIMATE CHANGE
    • Y02A—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE
    • Y02A50/00—TECHNOLOGIES FOR ADAPTATION TO CLIMATE CHANGE in human health protection, e.g. against extreme weather
    • Y02A50/30—Against vector-borne diseases, e.g. mosquito-borne, fly-borne, tick-borne or waterborne diseases whose impact is exacerbated by climate change

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Zoology (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Wood Science & Technology (AREA)
  • Biotechnology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biochemistry (AREA)
  • Medicinal Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • General Engineering & Computer Science (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Microbiology (AREA)
  • Veterinary Medicine (AREA)
  • Biophysics (AREA)
  • Mycology (AREA)
  • Communicable Diseases (AREA)
  • Public Health (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Oncology (AREA)
  • Molecular Biology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Peptides Or Proteins (AREA)
  • Compounds Of Unknown Constitution (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
ZA839269A 1982-12-20 1983-12-13 Antibiotic a51568 factors a and b ZA839269B (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US45088082A 1982-12-20 1982-12-20

Publications (1)

Publication Number Publication Date
ZA839269B true ZA839269B (en) 1985-07-31

Family

ID=23789893

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA839269A ZA839269B (en) 1982-12-20 1983-12-13 Antibiotic a51568 factors a and b

Country Status (24)

Country Link
EP (1) EP0112184B1 (ro)
JP (2) JPS59118798A (ro)
KR (1) KR860001497B1 (ro)
AT (1) ATE42571T1 (ro)
AU (1) AU563466B2 (ro)
CA (1) CA1214413A (ro)
DD (1) DD210709A1 (ro)
DE (1) DE3379735D1 (ro)
DK (1) DK167688B1 (ro)
EG (1) EG16163A (ro)
ES (1) ES528197A0 (ro)
FI (1) FI834594A (ro)
GB (1) GB2132207B (ro)
GR (1) GR78784B (ro)
HK (1) HK72088A (ro)
HU (1) HU192971B (ro)
IE (1) IE56382B1 (ro)
IL (1) IL70441A (ro)
NZ (1) NZ206592A (ro)
PH (1) PH20198A (ro)
PT (1) PT77810A (ro)
RO (1) RO87735A2 (ro)
SU (1) SU1194285A3 (ro)
ZA (1) ZA839269B (ro)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE3572178D1 (en) * 1984-04-16 1989-09-14 Lilly Co Eli Improvements in and relating to antibiotics m43a, m43b, m43c and m43d
IL78597A0 (en) * 1985-04-25 1986-08-31 Lilly Co Eli Novel glycopeptide derivatives
JP2577133B2 (ja) * 1989-11-27 1997-01-29 スティフティング フォール ド テフニスヘ ウェッテンスハッペン 船舶のプロペラ
RU2633511C1 (ru) * 2016-06-29 2017-10-12 Федеральное государственное бюджетное научное учреждение "Научно-исследовательский институт по изысканию новых антибиотиков имени Г.Ф. Гаузе" Штамм Amycolatopsis orientalis - продуцент антибиотика диметилванкомицина и способ получения антибиотика

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4322406A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Antibiotic A-4696 factors B1, B2, B3, C1a, C3 and E1
US4322343A (en) * 1980-12-18 1982-03-30 Eli Lilly And Company Pseudo-aglycone of actaplanin

Also Published As

Publication number Publication date
EP0112184B1 (en) 1989-04-26
DE3379735D1 (en) 1989-06-01
SU1194285A3 (ru) 1985-11-23
GB2132207B (en) 1986-06-04
GB8333668D0 (en) 1984-01-25
RO87735A2 (ro) 1985-10-31
AU563466B2 (en) 1987-07-09
IE56382B1 (en) 1991-07-17
NZ206592A (en) 1987-02-20
IE832990L (en) 1984-06-20
ES8504935A1 (es) 1985-05-01
JPH0771479B2 (ja) 1995-08-02
PT77810A (en) 1984-01-01
DK167688B1 (da) 1993-12-06
IL70441A0 (en) 1984-03-30
GB2132207A (en) 1984-07-04
EP0112184A2 (en) 1984-06-27
EP0112184A3 (en) 1985-06-19
ATE42571T1 (de) 1989-05-15
DD210709A1 (de) 1984-06-20
EG16163A (en) 1989-01-30
JPH05168466A (ja) 1993-07-02
HU192971B (en) 1987-08-28
FI834594A (fi) 1984-06-21
JPS59118798A (ja) 1984-07-09
HK72088A (en) 1988-09-16
FI834594A0 (fi) 1983-12-14
AU2242683A (en) 1984-06-28
GR78784B (ro) 1984-10-02
PH20198A (en) 1986-10-16
KR840007437A (ko) 1984-12-07
IL70441A (en) 1986-11-30
DK578083D0 (da) 1983-12-15
KR860001497B1 (ko) 1986-09-27
RO87735B1 (ro) 1985-10-01
ES528197A0 (es) 1985-05-01
DK578083A (da) 1984-06-21
JPH0430400B2 (ro) 1992-05-21
CA1214413A (en) 1986-11-25

Similar Documents

Publication Publication Date Title
AU572851B2 (en) Leucine derivatives
AU5486694A (en) Lactone compound and process of production thereof
DE3379735D1 (en) Antibiotic a51568 factors a and b
IE811462L (en) Preparing tylactone.
ES8406546A1 (es) Preparacion del nuevo complejo antibiotico cp-55358.
BG40817A3 (en) Method for preparation of macrolidic antibiotics
IE821067L (en) Narasin
ES2060962T3 (es) Antibioticos glicopeptidicos.
JPS5511541A (en) Novel antibiotics and their preparation